Ratnakar Securities Pvt. Ltd.

BLUE JET HEALTHCARE LTD.

NSE : BLUEJETBSE : 544009ISIN CODE : INE0KBH01020Industry : Pharmaceuticals & DrugsHouse : Private

BSE545.00-10.4 (-1.87 %)

PREV CLOSE ( ) 555.40

OPEN PRICE ( ) 552.15

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 14504

TODAY'S LOW / HIGH ( )540.75 558.30

52 WK LOW / HIGH ( )491.65 1028.2

Select year

Particulars	Mar2021	Mar2020
Operational & Financial Ratios
Earnings Per Share (Rs)	1396.44	24141.17
CEPS(Rs)	8.96	0.00
DPS(Rs)	0.00	0.00
Book NAV/Share(Rs)	3428.35	32017.33
Tax Rate(%)	26.47	25.33
Margin Ratios
Core EBITDA Margin(%)	41.30	39.71
EBIT Margin(%)	38.07	37.44
Pre Tax Margin(%)	37.01	36.07
PAT Margin (%)	27.22	26.93
Cash Profit Margin (%)	31.16	30.29
Performance Ratios
ROA(%)	26.50	33.58
ROE(%)	51.06	75.46
ROCE(%)	56.68	72.23
Asset Turnover(x)	0.97	1.25
Sales/Fixed Asset(x)	3.31	4.30
Working Capital/Sales(x)	2.20	4.66
Efficiency Ratios
Fixed Capital/Sales(x)	0.30	0.23
Receivable days	96.02	80.36
Inventory Days	68.30	46.80
Payable days	120.13	90.23
Valuation Parameters
PER(x)	0.00	0.00
PCE(x)	0.00	0.00
Price/Book(x)	0.00	0.00
Yield(%)
EV/Net Sales(x)	-0.02	0.12
EV/Core EBITDA(x)	-0.04	0.29
EV/EBIT(x)	-0.05	0.31
EV/CE(x)	-0.02	0.23
M Cap / Sales	0.00	0.00
Growth Ratio
Net Sales Growth(%)	-7.30	0.00
Core EBITDA Growth(%)	-2.10	0.00
EBIT Growth(%)	-5.72	0.00
PAT Growth(%)	-6.33	0.00
EPS Growth(%)	-94.22	0.00
Financial Stability Ratios
Total Debt/Equity(x)	0.15	0.40
Current Ratio(x)	2.03	1.60
Quick Ratio(x)	1.50	1.24
Interest Cover(x)	35.79	27.34
Total Debt/Mcap(x)

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Financial Ratios

BLUE JET HEALTHCARE LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES